NEW ORLEANS – Natural killer (NK) cells derived from cord blood that were activated and complexed with a CD30/CD16A bispecific antibody elicited an 89 percent overall response rate in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results